CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-16 | FREEMAN KEVIN D Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2025-12-23 | FREEMAN KEVIN D Director | Purchase | +5,500 | $3.55 | $20K | 55,269 |
| 2025-12-23 | FREEMAN KEVIN D Director | Purchase 10b5-1 | +5,500 | $3.55 | $20K | 55,269 |
| 2025-12-23 | FREEMAN KEVIN D Director | Purchase 10b5-1 | +5,500 | $3.55 | $20K | 55,269 |
| 2025-07-17 | FREEMAN KEVIN D Director | Purchase | +5,000 | $2.90 | $14K | 49,769 |
| 2025-01-23 | FREEMAN KEVIN D Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-12-24 | FREEMAN KEVIN D Director | Purchase | +10,000 | $0.81 | $8K | 44,769 |
| 2024-10-17 | FREEMAN KEVIN D Director | Purchase | +1,300 | $2.64 | $3K | 34,769 |
| 2024-10-16 | FREEMAN KEVIN D Director | Purchase | +5,000 | $2.70 | $14K | 33,469 |
| 2024-10-16 | FREEMAN KEVIN D Director | Purchase | +5,000 | $2.70 | $14K | 80,000 |
| 2024-06-20 | FREEMAN KEVIN D Director | Purchase | +2,500 | $2.38 | $6K | 28,469 |
| 2024-04-22 | FREEMAN KEVIN D Director | Purchase | +2,500 | $2.98 | $7K | 25,969 |
| 2024-04-09 | FREEMAN KEVIN D Director | Other acquisition | +2,063 | 18,063 | ||
| 2024-01-24 | FREEMAN KEVIN D Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-01-26 | FREEMAN KEVIN D Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-10-28 | FREEMAN KEVIN D Director | Purchase | +10,000 | $1.41 | $14K | 75,000 |
| 2022-05-19 | FREEMAN KEVIN D Director | Purchase | +5,000 | $1.33 | $7K | 65,000 |
| 2022-04-18 | FREEMAN KEVIN D Director | Purchase | +5,000 | $1.71 | $9K | 60,000 |
| 2022-01-24 | FREEMAN KEVIN D Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-19 | FREEMAN KEVIN D Director | Purchase | +5,000 | $1.96 | $10K | 55,000 |
Page 1 of 2 · 36 trades